Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD - Results from the ABACOPD study
G. Rohde (Frankfurt am Main, Germany), S. Häckl (Hannover, Germany), A. Koch (Hannover, Germany), M. Kolditz (Dresden, Germany), H. Timmermann (Hamburg, Germany), S. Andreas (Immenhausen, Germany), G. Barten (Hannover, Germany), T. Welte (Hannover, Germany), T. Abacopd Study Group (Hannover, Germany)
Source: International Congress 2022 – COPD treatment: new mechanisms and novel insights
Session: COPD treatment: new mechanisms and novel insights
Session type: Oral Presentation
Number: 753
   
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Rohde (Frankfurt am Main, Germany), S. Häckl (Hannover, Germany), A. Koch (Hannover, Germany), M. Kolditz (Dresden, Germany), H. Timmermann (Hamburg, Germany), S. Andreas (Immenhausen, Germany), G. Barten (Hannover, Germany), T. Welte (Hannover, Germany), T. Abacopd Study Group (Hannover, Germany). Randomized double blind placebo-controlled study to demonstrate that antibiotics are not needed in moderate acute exacerbations of COPD - Results from the ABACOPD study. 753
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|